JADPRO Live 2024 | Cancer Nursing Today
Find important meeting news and updates from JADPRO Live 2024, the Annual APSHO Meeting, held November 14-17, in Grapevine, Texas.
Related Articles
Israel kills Hamas commander who led one of most heinous Oct. 7…
Hamas methodically burned all 250 cars at the kibbutz during the attack so that residents who weren’t immediately murdered or abducted couldn’t escape
Zamto-cel shows promise in interim results from phase 2 pivotal study
SOHO Insider spoke with Toon Overstijns, CEO of Miltenyi Biomedicine, and Dr. Anna Wijatyk, CMO (USA) of Miltenyi Biomedicine, at the 66th American Society of…
1 in 5 People Have This Heart Disease Risk Factor—and Don’t Know It
Knowledge is power. Cardiologists reveal how to protect yourself.
7 Of The Best Canned Foods To Enjoy Right Now (And Always)
Add these tasty and nutritious options to your pantry, stat.
Real-Time Revolution: The Adaptive TMVR Solution
Mitral regurgitation (MR) is one of the most common valvular heart diseases and has a prevalence of 2% in the general population. 1 MR is…
Revolutionizing Lung Cancer Care: Unveiling ESMO 2023’s Takeaways
Drs. Hossein Borghaei and Tony Calles dissect the pivotal abstracts and cutting-edge data unveiled at ESMO 2023, spotlighting the transformative landscape of…
Magnetic Resonance-Guided Stereotactic Radioablation for Septal Ventricular Tachycardias:
AbstractBackgroundStereotactic arrhythmia radioablation (STAR) was introduced to treat ventricular tachycardia (VT) refractory to catheter ablation. No data are now available in the septal VT subst…
Association of Urinary Sodium Excretion With IgAN Progression | Docwire News
Researchers examined the role of urinary sodium excretion and the progression of IgA nephropathy (IgAN).
Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer:
AbstractBackgroundCardiovascular diseases are associated with higher cancer risk. However, their relationship with metastatic cancer, the primary determinant of cancer prognosis, has not been studi…
COUNTERPOINT: Abandon or Reassess? Interpretating Treatment Effects in ”Negative” Clinical Trials
P-values are increasingly viewed with skepticism (Wasserstein et al 2016) and clinicians are searching for alternative or supplementary measures of evidence. This is particularly relevant…
